Synergy Pharmaceuticals Raises $8.6 Million in Common Stock Financing
11/12/2009 6:51:57 AM
More...
|
Synergy Pharmaceuticals Announces Appointment of Dr. Alan F. Joslyn to Board of Directors
10/8/2009 8:13:25 AM
More...
|
Synergy Pharmaceuticals Raises $7.09 Million in Common Stock Financing
7/7/2009 9:46:55 AM
More...
|
Synergy Pharmaceuticals to Present Phase I Volunteer Study on SP-304 Investigational Drug to Treat GI Disorders at Upcoming Conference
5/27/2009 9:00:14 AM
More...
|
Synergy Pharmaceuticals Successfully Completes Phase I Trial of SP-304 in Volunteers
12/9/2008 9:16:34 AM
More...
|
Dr. Mel Spigelman, Director of Synergy Pharmaceuticals, Appointed President and CEO of Global Alliance For TB Drug Development
10/15/2008 9:18:58 AM
More...
|
Synergy Pharmaceuticals Announces Appointment of Dr. Mel Spigelman to Board of Directors
8/28/2008 8:43:55 AM
More...
|
Synergy Pharmaceuticals Effects Name Change and Forward Stock Split
8/11/2008 8:08:40 AM
More...
|
Callisto Pharmaceuticals Announces $3.0 Million Financing by Its Synergy Pharmaceuticals Subsidiary and Related Transactions Leaving Callisto with a 68% Stake in Synergy
7/21/2008 11:08:20 AM
More...
|